Capricor Therapeutics Inc
CAPR Real Time Price USDRecent trades of CAPR by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CAPR's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Chimeric natriuretic peptide compositions and methods of preparation Apr. 18, 2017
-
Patent Title: Therapy for kidney disease and/or heart failure Apr. 11, 2017
-
Patent Title: Methods of treatment of heart failure with natriuretic peptides Apr. 19, 2016
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of CAPR in WallStreetBets Daily Discussion
Recent insights relating to CAPR
Recent picks made for CAPR stock on CNBC
ETFs with the largest estimated holdings in CAPR
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CAPR Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.